INmune Bio, Inc. (INMB) NASDAQ
1.42
+0.03(+2.16%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
1.42
+0.03(+2.16%)
Currency In USD
| Market Cap | 41.47M |
| Enterprise Value | 17.76M |
| P/E Ratio | -0.91 |
| PEG Ratio | -1.02 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 1.92 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.67 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -1.61 |
| Return On Equity | -1.71 |
| Revenue | 50,000 |
| Revenue/Share | 0 |
| Gross Profit | 50,000 |
| EBITDA | -30.79M |
| Net Income | -45.93M |
| Diluted EPS | -1.86 |
| Total Cash | 21.36M |
| Total Cash/Share | 0.8 |
| Total Debt | 1.51M |
| Total Debt/Equity | 0.08 |
| Current Ratio | 4.24 |
| Book Value Per Share | 0.74 |
| 52-Week Change | -80.25 |
| 52-Week High | 11.64 |
| 52-Week Low | 1.09 |
| Moving Average 50 Days | 1.36 |
| Moving Average 200 Days | 1.64 |
| Average Volume | 429,653 |
| Shares Outstanding | 26.59M |
| % Held by Institutions | 20.21 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |